导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.53% | 890/1050 |
| 近一周 | -3.00% | 920/1104 |
| 近一月 | -2.80% | 502/1103 |
| 近一季 | -1.65% | 348/1092 |
| 近半年 | -10.89% | 801/1070 |
| 近一年 | -11.26% | 766/1018 |
| 近两年 | 29.22% | 690/926 |
| 近三年 | 15.65% | 551/834 |
| 成立以来 | 77.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.63% 890/1070 |
-7.70% 858/1101 |
- - |
- - |
| 2025 | 26.89% 540/1065 |
4.41% 451/1014 |
3.11% 427/1038 |
18.84% 637/1050 |
-0.83% 488/1065 |
| 2024 | 17.51% 124/1011 |
1.56% 228/960 |
4.14% 129/983 |
14.92% 231/991 |
-3.32% 555/1011 |
| 2023 | -14.37% 497/952 |
1.54% 538/880 |
-7.77% 687/895 |
-0.39% 98/915 |
-8.21% 774/952 |
| 2022 | -17.08% 224/867 |
-18.08% 431/773 |
11.27% 216/806 |
-14.20% 520/845 |
6.01% 166/867 |
| 2021 | -9.67% 484/740 |
1.94% 90/580 |
5.19% 464/659 |
-14.37% 594/704 |
-1.62% 501/740 |
| 2020 | 64.75% 167/554 |
-6.20% 322/419 |
26.20% 179/466 |
13.54% 170/517 |
22.58% 93/554 |
| 2019 | 43.82% 193/410 |
23.31% 824/1146 |
0.46% 284/1228 |
5.70% 189/390 |
9.84% 164/410 |
| 2018 | - - |
- - |
-1.08% 100/990 |
-4.82% 447/1000 |
-12.46% 651/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 嘉实核心优势股票发起式 VS. 东吴新产业精选股票A(580008) |